[Congressional Record Volume 167, Number 188 (Tuesday, October 26, 2021)]
[House]
[Pages H5928-H5929]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                     EXECUTIVE COMMUNICATIONS, ETC.

  Under clause 2 of rule XIV, executive communications were taken from 
the Speaker's table and referred as follows:


[[Page H5929]]


  

       EC-2517. A letter from the Assistant Secretary, Securities 
     and Exchange Commission, transmitting the Commission's final 
     rule -- Filing Fee Disclosure and Payment Methods 
     Modernization [Release Nos.: 33-10997; 34-93285; IC-34396; 
     File No. S7-20-19] (RIN: 3235-AL96) received October 20, 
     2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, 
     Sec. 251; (110 Stat. 868); to the Committee on Financial 
     Services.
       EC-2518. A letter from the Senior Policy Analyst, Office of 
     the Under Secretary for Economic Affairs, Department of 
     Commerce, transmitting the Department's final rule -- 
     Concrete Masonry Products Research, Education, and Promotion 
     Order [Docket No.: 210820-0165] (RIN: 0605-AA53) received 
     September 30, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public 
     Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on 
     Energy and Commerce.
       EC-2519. A letter from the Director, Regulations Policy and 
     Management Staff, FDA, Department of Health and Human 
     Services, transmitting the Department's final rule -- Listing 
     of Color Additives Exempt From Certification; Silver Nitrate 
     [Docket No.: FDA-2018-C-0617] received October 14, 2021, 
     pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 
     251; (110 Stat. 868); to the Committee on Energy and 
     Commerce.
       EC-2520. A letter from the Director, Regulations Policy and 
     Management Staff, FDA, Department of Health and Human 
     Services, transmitting the Department's final rule -- Medical 
     Device De Novo Classification Process [Docket No.: FDA-2018-
     N-0236] (RIN: 0910-AH53) received October 14, 2021, pursuant 
     to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 
     Stat. 868); to the Committee on Energy and Commerce.
       EC-2521. A letter from the Director, Regulations Policy and 
     Management Staff, FDA, Department of Health and Human 
     Services, transmitting the Department's final rule -- 
     Premarket Tobacco Product Applications and Recordkeeping 
     Requirements [Docket No.: FDA-2019-N-2854] (RIN: 0910-AH44) 
     received October 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); 
     Public Law 104-121, Sec. 251; (110 Stat. 868); to the 
     Committee on Energy and Commerce.
       EC-2522. A letter from the Director, Regulations Policy and 
     Management Staff, FDA, Department of Health and Human 
     Services, transmitting the Department's final rule -- Content 
     and Format of Substantial Equivalence Reports; Food and Drug 
     Administration Actions on Substantial Equivalence Reports 
     [Docket No.: FDA-2016-N-3818] (RIN: 0910-AH89) received 
     October 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public 
     Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on 
     Energy and Commerce.
       EC-2523. A letter from the Associate Division Director, 
     Regulatory Management Division, Environmental Protection 
     Agency, transmitting the Agency's final rule -- Air Plan 
     Approval; California; Antelope Valley Air Quality Management 
     District, Eastern Kern Air Pollution Control District, and 
     Yolo-Solano Air Quality Management District; Combustion 
     Sources; Correcting Amendment [EPA-R09-OAR-2020-0476; FRL-
     8777-03-R9] received October 14, 2021, pursuant to 5 U.S.C. 
     801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); 
     to the Committee on Energy and Commerce.
       EC-2524. A letter from the Associate Division Director, 
     Regulatory Management Division, Environmental Protection 
     Agency, transmitting the Agency's final rule -- Pseudomonas 
     Fluorescens Strain ACK55; Exemption From the Requirement of a 
     Tolerance; Technical Correction [EPA-HQ-OPP-2017-0335; FRL-
     9000-01-OCSPP] received October 14, 2021], pursuant to 5 
     U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 
     868); to the Committee on Energy and Commerce.
       EC-2525. A letter from the Associate Division Director, 
     Regulatory Management Division, Environmental Protection 
     Agency, transmitting the Agency's final rule -- Significant 
     New Use Rules on Certain Chemical Substances (21-2.B) [EPA-
     HQ-OPPT-2020-0581; FRL-8585-01-OCSPP] (RIN: 2070-AB27) 
     received October 14, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); 
     Public Law 104-121, Sec. 251; (110 Stat. 868); to the 
     Committee on Energy and Commerce.
       EC-2526. A letter from the Associate Division Director, 
     Regulatory Management Division, Environmental Protection 
     Agency, transmitting the Agency's final rule -- Clothianidin; 
     Pesticide Tolerances [EPA-HQ-OPP-2020-0511; FRL-8667-01-
     OCSPP] received October 14, 2021, pursuant to 5 U.S.C. 
     801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); 
     to the Committee on Energy and Commerce.
       EC-2527. A letter from the Associate Division Director, 
     Regulatory Management Division, Environmental Protection 
     Agency, transmitting the Agency's correcting amendment -- 
     Clean Air Plans; 2008 8-Hour Ozone Nonattainment Area 
     Requirements; West Mojave Desert, California [EPA-R09-OAR-
     2020-0254; FRL-8727-03-R9] received October 14, 2021, 
     pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 
     251; (110 Stat. 868); to the Committee on Energy and 
     Commerce.
       EC-2528. A letter from the Director, Office of Regulatory 
     Affairs and C.A., Bureau of Indian Affairs, Department of the 
     Interior, transmitting the Department's final rule -- Indian 
     Land Title and Records [212A2100DD/AAKC001030/
     A0A501010.999900] (RIN: 1076-AF56) received October 25, 2021, 
     pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 
     251; (110 Stat. 868); to the Committee on Natural Resources.
       EC-2529. A letter from the Adjutant General, Veterans of 
     Foreign Wars, transmitting the proceedings of the 121st 
     National Pro-Forma Convention of the Veterans of Foreign Wars 
     of the United States, held in Kansas City, Missouri, July 24, 
     2020, pursuant to 44 U.S.C. 1332; Public Law 90-620 (as 
     amended by Public Law 105-225, Sec. 3); (112 Stat. 1498) (H. 
     Doc. No. 117--68); to the Committee on Veterans' Affairs and 
     ordered to be printed.
       EC-2530. A letter from the Director, Legal Processing 
     Division, Internal Revenue Service, transmitting the 
     Service's Major final rule -- Requirements Related to 
     Surprise Billing; Part II [TD 9955] (RIN: 1545-BQ05) received 
     October 19, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); Public 
     Law 104-121, Sec. 251; (110 Stat. 868); to the Committee on 
     Ways and Means.
       EC-2531. A letter from the Director, Legal Processing 
     Division, Internal Revenue Service, transmitting the 
     Service's final rule -- Certain Non-Government Persons Not 
     Authorized To Participate in Examinations of Books and 
     Witnesses as a Section 6103(n) Contractor [TD 9952] (RIN: 
     1545-B012) received October 8, 2021, pursuant to 5 U.S.C. 
     801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); 
     to the Committee on Ways and Means.
       EC-2532. A letter from the Director, Legal Processing 
     Division, Internal Revenue Service, transmitting the 
     Service's IRB only rule -- Revenue Procedure: Examination of 
     returns and claims for refund, credit, or abatement; 
     determination of correct tax liability (Rev. Proc. 2021-41) 
     received October 8, 2021, pursuant to 5 U.S.C. 801(a)(1)(A); 
     Public Law 104-121, Sec. 251; (110 Stat. 868); to the 
     Committee on Ways and Means.

                          ____________________